Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification

Schlotawa L, Adang LA, Radhakrishnan K, Ahrens-Nicklas RC (2020)
International journal of molecular sciences 21(10): 3448.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 1.18 MB
Autor*in
Schlotawa, Lars; Adang, Laura A; Radhakrishnan, KarthikeyanUniBi; Ahrens-Nicklas, Rebecca C
Abstract / Bemerkung
Multiple sulfatase deficiency (MSD, MIM #272200) is an ultra-rare disease comprising pathophysiology and clinical features of mucopolysaccharidosis, sphingolipidosis and other sulfatase deficiencies. MSD is caused by impaired posttranslational activation of sulfatases through the formylglycine generating enzyme (FGE) encoded by the sulfatase modifying factor 1 (SUMF1) gene, which is mutated in MSD. FGE is a highly conserved, non-redundant ER protein that activates all cellular sulfatases by oxidizing a conserved cysteine in the active site of sulfatases that is necessary for full catalytic activity. SUMF1 mutations result in unstable, degradation-prone FGE that demonstrates reduced or absent catalytic activity, leading to decreased activity of all sulfatases. As the majority of sulfatases are localized to the lysosome, loss of sulfatase activity induces lysosomal storage of glycosaminoglycans and sulfatides and subsequent cellular pathology. MSD patients combine clinical features of all single sulfatase deficiencies in a systemic disease. Disease severity classifications distinguish cases based on age of onset and disease progression. A genotype- phenotype correlation has been proposed, biomarkers like excreted storage material and residual sulfatase activities do not correlate well with disease severity. The diagnosis of MSD is based on reduced sulfatase activities and detection of mutations in SUMF1. No therapy exists for MSD yet. This review summarizes the unique FGE/ sulfatase physiology, pathophysiology and clinical aspects in patients and their care and outlines future perspectives in MSD.
Erscheinungsjahr
2020
Zeitschriftentitel
International journal of molecular sciences
Band
21
Ausgabe
10
Seite(n)
3448
eISSN
1422-0067
Page URI
https://pub.uni-bielefeld.de/record/2943713

Zitieren

Schlotawa L, Adang LA, Radhakrishnan K, Ahrens-Nicklas RC. Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. International journal of molecular sciences. 2020;21(10):3448.
Schlotawa, L., Adang, L. A., Radhakrishnan, K., & Ahrens-Nicklas, R. C. (2020). Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. International journal of molecular sciences, 21(10), 3448. https://doi.org/10.3390/ijms21103448
Schlotawa, Lars, Adang, Laura A, Radhakrishnan, Karthikeyan, and Ahrens-Nicklas, Rebecca C. 2020. “Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification”. International journal of molecular sciences 21 (10): 3448.
Schlotawa, L., Adang, L. A., Radhakrishnan, K., and Ahrens-Nicklas, R. C. (2020). Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. International journal of molecular sciences 21, 3448.
Schlotawa, L., et al., 2020. Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. International journal of molecular sciences, 21(10), p 3448.
L. Schlotawa, et al., “Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification”, International journal of molecular sciences, vol. 21, 2020, pp. 3448.
Schlotawa, L., Adang, L.A., Radhakrishnan, K., Ahrens-Nicklas, R.C.: Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. International journal of molecular sciences. 21, 3448 (2020).
Schlotawa, Lars, Adang, Laura A, Radhakrishnan, Karthikeyan, and Ahrens-Nicklas, Rebecca C. “Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification”. International journal of molecular sciences 21.10 (2020): 3448.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-11-15T15:55:54Z
MD5 Prüfsumme
d1effd807d661302577091187f87b0ae


Link(s) zu Volltext(en)
Access Level
OA Open Access

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 32414121
PubMed | Europe PMC

Suchen in

Google Scholar